<DOC>
	<DOCNO>NCT00368537</DOCNO>
	<brief_summary>The purpose study compare safety efficacy antibiotic tigecycline antibiotic , ampicillin-sulbactam , amoxicillin-clavulanate treatment complicate skin and/or skin structure infection ( cSSSI ) .</brief_summary>
	<brief_title>Study Comparing Safety Efficacy Tigecycline With Ampicillin-Sulbactam Amoxicillin-Clavulanate Treat Skin Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases , Bacterial</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Clinical diagnosis complicate skin skin structure infection Male female , 18 year old Need intravenous treatment 4 14 day Skin infection treat surgery &amp; wound care alone Diabetic foot ulcer bedsores infection present longer 1 week Poor circulation amputation infect site likely within month Other exclusion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>skin infection</keyword>
	<keyword>antibiotic</keyword>
</DOC>